The global non-small cell lung cancer market is projected to grow significantly over the forecast period, reaching US$ 55.25 billion by 2034 from US$ 21.95 billion in 2025, registering a robust CAGR of 10.80% during 2026–2034. The market growth is primarily driven by increasing incidence of lung cancer worldwide, rising demand for precision oncology solutions, and continuous innovation in...